ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies
ASCO Updates Guideline On Antiemetics
New Drug Combination Shrinks Kidney Cancers
Docetaxel, Oxaliplatin Active Against Esophageal Cancer
BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery
Communication Is Key To Clinical Trial Enrollment
FDA Approves Treatment For Late-Stage Cervical Cancer
NCI-Approved Clinical Trials
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40% - California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus
- In the epicenter of the measles outbreak, “love thy neighbor” does not extend to vaccination rates
A dispatch from Lancaster County - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









